Vascular Biogenics Stock Z Score
VBLTDelisted Stock  USD 0.28 0.01 3.45% 
Vascular 
Vascular Biogenics Company Z Score Analysis
Vascular Biogenics' ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Vascular Biogenics Z Score  2.01 
Most of Vascular Biogenics' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vascular Biogenics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 
 
 
 

To calculate a ZScore, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. ZScores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize zscores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionAs per the company's disclosures, Vascular Biogenics has a Z Score of 2.01. This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The z score for all United States stocks is notably higher than that of the company.
Vascular Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vascular Biogenics' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vascular Biogenics could also be used in its relative valuation, which is a method of valuing Vascular Biogenics by comparing valuation metrics of similar companies.Vascular Biogenics is currently under evaluation in z score category among its peers.
Vascular Fundamentals
Return On Equity  0.6  
Return On Asset  0.29  
Operating Margin  (33.89) %  
Current Valuation  (10.99 M)  
Shares Outstanding  77.64 M  
Shares Owned By Insiders  13.48 %  
Shares Owned By Institutions  14.00 %  
Number Of Shares Shorted  250.34 K  
Price To Earning  (9.32) X  
Price To Book  0.35 X  
Price To Sales  9.63 X  
Revenue  658 K  
Gross Profit  554 K  
EBITDA  (31.16 M)  
Net Income  (32.3 M)  
Cash And Equivalents  34.15 M  
Cash Per Share  0.49 X  
Total Debt  564 K  
Debt To Equity  0.05 %  
Current Ratio  4.05 X  
Book Value Per Share  0.27 X  
Cash Flow From Operations  (31.59 M)  
Short Ratio  0.55 X  
Earnings Per Share  (0.18) X  
Target Price  5.0  
Beta  0.71  
Market Capitalization  13.83 M  
Total Asset  29.66 M  
Retained Earnings  (294.38 M)  
Working Capital  15.42 M  
Current Asset  38.59 M  
Current Liabilities  4.16 M  
Z Score  2.01  
Net Asset  29.66 M 
About Vascular Biogenics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vascular Biogenics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vascular Biogenics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vascular Biogenics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Vascular Biogenics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vascular Biogenics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vascular Biogenics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Vascular Biogenics could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace Vascular Biogenics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vascular Biogenics  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vascular Biogenics to buy it.
The correlation of Vascular Biogenics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vascular Biogenics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vascular Biogenics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vascular Biogenics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
RiskReturn Analysis View associations between returns expected from investment and the risk you assume  
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities  
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine  
Content Syndication Quickly integrate customizable finance content to your own investment portal  
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators  
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and roboadvisors.  
Bonds Directory Find actively traded corporate debentures issued by US companies  
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments  
Financial Widgets Easily integrated Macroaxis content with over 30 different plugandplay financial widgets 